Lisata Therapeutics Hits Enrollment Milestone for Pancreatic Cancer Trial
By Daniella Parra Lisata Therapeutics (Nasdaq: LSTA), said it has fully enrolled the pancreatic cancer...
By Daniella Parra Lisata Therapeutics (Nasdaq: LSTA), said it has fully enrolled the pancreatic cancer...
By Karen Roman Aktis Oncology said it appointed Dr. Ken Herrmann to the Board of...
By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said the FDA allowed the beginning of...
By Daniella Parra Imperium Health and DecisionRx are teaming up to provide free Medication Therapy...
By Karen Roman The Duckhorn Portfolio, Inc. (NYSE: NAPA) reported net sales increased 1.4% year...
By Karen Roman MOBILion Systems announced it is presenting the latest features of its mass...
By Daniella Parra Sparrow Pharmaceuticals said its HSD-1 inhibitor, clofutriben (SPI-62), normalized urine free cortisol...
New School photos courtesy of Dar Charity Foundation Furthering Nikita Mishin’s Educational Vision By Exec...
By Daniella Parra Kohl’s Corp. (NYSE:KSS) said regular price sales increased 2.4% in the first...
By Karen Roman Movado Group, Inc. (NYSE: MOV) maintained guidance for fiscal 2025 with net...